IL6R and rheumatoid arthritis: Interestingly, Tocilizumab, a humanized anti-IL-6 receptor (anti-IL-6R) monoclonal antibody, reduces sleepiness in patients with rheumatoid arthritis (Townes et al., 2012), which may be related to improvements in sleep quality due to better control of sleep disturbance caused by pain and discomfort.